Sarepta Therapeutics (SRPT) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.36% |
| Dec 31, 2025 | 22.44% |
| Sep 30, 2025 | 42.80% |
| Jun 30, 2025 | 34.67% |
| Mar 31, 2025 | -23.98% |
| Dec 31, 2024 | 20.70% |
| Sep 30, 2024 | -0.95% |
| Jun 30, 2024 | 16.96% |
| Mar 31, 2024 | -10.61% |
| Dec 31, 2023 | 14.89% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.84% |
| Mar 31, 2023 | -42.47% |
| Dec 31, 2022 | -24.36% |
| Sep 30, 2022 | -2.33% |
| Jun 30, 2022 | 4.73% |
| Mar 31, 2022 | -11.81% |
| Dec 31, 2021 | 18.43% |
| Sep 30, 2021 | -15.45% |
| Jun 30, 2021 | -20.32% |
| Mar 31, 2021 | -24.34% |
| Dec 31, 2020 | -41.04% |
| Sep 30, 2020 | -38.75% |
| Jun 30, 2020 | -30.41% |
| Mar 31, 2020 | 75.15% |
| Dec 31, 2019 | -45.12% |
| Sep 30, 2019 | -13.81% |
| Jun 30, 2019 | -14.87% |
| Mar 31, 2019 | -38.92% |
| Dec 31, 2018 | -47.02% |
| Sep 30, 2018 | -41.64% |
| Jun 30, 2018 | -57.75% |
| Mar 31, 2018 | -18.93% |
| Dec 31, 2017 | -34.11% |
| Sep 30, 2017 | -49.30% |
| Jun 30, 2017 | -71.84% |
| Mar 31, 2017 | -44.94% |
| Dec 31, 2016 | -70.44% |
| Sep 30, 2016 | -51.79% |
| Jun 30, 2016 | -150.14% |
| Mar 31, 2016 | -43.24% |
| Dec 31, 2015 | -75.32% |
| Sep 30, 2015 | -75.61% |